https://www.selleckchem.com/pr....oducts/Verteporfin(V
INTRODUCTION Since 2018, World Health Organization (WHO) recommended the Xpert MTB/RIF Ultra use for pulmonary and extrapulmonary TB diagnosis, and suggested that Xpert Ultra should be tested in various populations, with different geographical and epidemiological settings. METHODS Cross-sectional study with prospective data collection. Outpatients aged 18 years with respiratory symptoms suggestive of pulmonary TB were invited to participate. Sensitivity, specificity, positive and negative predictive values of the test
Like
Comment
Share
